Objective The multifunctional Ca 2+ -binding protein S100A4 (also known as Mts1 and Fsp1)
is involved in fibrosis and tissue remodeling in several diseases including cancer, kidney …

While cardiac hypertrophy elicited by pathological stimuli eventually leads to cardiac
dysfunction, exercise‐induced hypertrophy does not. This suggests that a beneficial hypertrophic …

Third-degree atrioventricular block after acute myocardial infarction is considered to have
prognostic importance. However, its importance in conjunction with thrombolytic therapy and …

The angiotensin II (AngII) type 1 receptor (AT 1 R) is a seven‐transmembrane receptor well
established to activate extracellular signal‐regulated kinases 1 and 2 (ERK1/2) by discrete G …

The angiotensin II (AngII) type 1 receptor (AT 1 R) has been shown to activate extracellular
signal‐regulated kinases 1 and 2 (ERK1/2) through G proteins or G protein‐independently …

The angiotensin AT 1 receptor is an important pharmacological target in the treatment of
cardiovascular disorders, such as hypertension, diabetic nephropathy, cardiac hypertrophy, …

Aims Evaluation of patients with primary mitral valve insufficiency (MI) is best supported by
quantitative measures. Cardiovascular magnetic resonance imaging (CMR) offers flow and …

Aim [123] I-Ioflupane (DaTSCAN) binds to the presynaptic dopamine transporter (DAT) and
with a lower affinity to the serotonin transporter (SERT). We aimed to develop a novel method …

Transglutaminase type 2 (TG2) has been reported to be a candidate gene for maturity onset
diabetes of the young (MODY) because three different mutations that impair TG2 …

The angiotensin II type 1 (AT 1 ) receptor plays a key role in cardiovascular pathophysiology,
and it is a major pharmacologic target in the treatment of many cardiovascular disorders. …